| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lysophospholipids | 18 | 2023 | 66 | 3.360 |
Why?
|
| Sphingosine | 16 | 2023 | 74 | 3.080 |
Why?
|
| Endothelial Cells | 18 | 2024 | 459 | 2.100 |
Why?
|
| Lung | 24 | 2024 | 1258 | 1.840 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 11 | 2020 | 80 | 1.630 |
Why?
|
| Amifostine | 3 | 2024 | 51 | 1.620 |
Why?
|
| Endothelium, Vascular | 8 | 2018 | 433 | 1.590 |
Why?
|
| Reactive Oxygen Species | 12 | 2024 | 490 | 1.570 |
Why?
|
| Signal Transduction | 22 | 2024 | 3373 | 1.460 |
Why?
|
| Pseudomonas aeruginosa | 5 | 2021 | 202 | 1.320 |
Why?
|
| Pseudopodia | 3 | 2018 | 37 | 1.290 |
Why?
|
| Paxillin | 2 | 2021 | 59 | 1.260 |
Why?
|
| Pseudomonas Infections | 3 | 2019 | 99 | 1.200 |
Why?
|
| Ventilator-Induced Lung Injury | 9 | 2023 | 31 | 1.180 |
Why?
|
| Pneumonia | 4 | 2024 | 182 | 1.170 |
Why?
|
| Capillary Permeability | 10 | 2015 | 130 | 1.170 |
Why?
|
| Mitochondrial Dynamics | 3 | 2024 | 56 | 1.160 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 5 | 2024 | 196 | 1.120 |
Why?
|
| Acute Lung Injury | 5 | 2024 | 64 | 1.070 |
Why?
|
| Lipopolysaccharides | 7 | 2024 | 293 | 0.940 |
Why?
|
| Phospholipase D | 3 | 2020 | 13 | 0.920 |
Why?
|
| Blood-Air Barrier | 3 | 2020 | 6 | 0.910 |
Why?
|
| Cadherins | 4 | 2023 | 163 | 0.860 |
Why?
|
| Aldehyde-Lyases | 6 | 2021 | 15 | 0.800 |
Why?
|
| Sphingolipids | 2 | 2018 | 20 | 0.790 |
Why?
|
| Antigens, CD | 4 | 2020 | 466 | 0.760 |
Why?
|
| Receptors, Lysosphingolipid | 8 | 2023 | 37 | 0.760 |
Why?
|
| Lung Injury | 2 | 2019 | 53 | 0.740 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2020 | 6 | 0.720 |
Why?
|
| Mice | 35 | 2024 | 11737 | 0.710 |
Why?
|
| Cell Nucleus | 2 | 2021 | 599 | 0.680 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 506 | 0.680 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2016 | 85 | 0.660 |
Why?
|
| Phospholipids | 5 | 2012 | 111 | 0.650 |
Why?
|
| Inflammation | 7 | 2019 | 971 | 0.630 |
Why?
|
| Mice, Inbred C57BL | 18 | 2024 | 3209 | 0.620 |
Why?
|
| Cells, Cultured | 17 | 2017 | 2880 | 0.610 |
Why?
|
| Animals | 44 | 2024 | 27317 | 0.610 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 12 | 0.610 |
Why?
|
| Anion Transport Proteins | 2 | 2016 | 10 | 0.600 |
Why?
|
| Endothelium | 4 | 2012 | 58 | 0.600 |
Why?
|
| Cartilage, Articular | 1 | 2017 | 69 | 0.580 |
Why?
|
| NADPH Oxidases | 3 | 2016 | 82 | 0.580 |
Why?
|
| Bleomycin | 5 | 2024 | 102 | 0.570 |
Why?
|
| Phosphorylation | 5 | 2021 | 1130 | 0.540 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2021 | 43 | 0.540 |
Why?
|
| Mitochondria | 5 | 2024 | 553 | 0.520 |
Why?
|
| Hyperoxia | 3 | 2021 | 35 | 0.510 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2015 | 30 | 0.500 |
Why?
|
| NADP | 1 | 2013 | 45 | 0.440 |
Why?
|
| Pneumonia, Bacterial | 1 | 2013 | 29 | 0.440 |
Why?
|
| Cell Movement | 1 | 2016 | 783 | 0.430 |
Why?
|
| Guanine Nucleotide Exchange Factors | 6 | 2010 | 73 | 0.420 |
Why?
|
| Aldehydes | 3 | 2021 | 19 | 0.410 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 59 | 0.390 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 432 | 0.370 |
Why?
|
| Bronchoalveolar Lavage Fluid | 6 | 2024 | 126 | 0.360 |
Why?
|
| Cell Cycle Proteins | 3 | 2020 | 401 | 0.350 |
Why?
|
| Humans | 42 | 2024 | 89063 | 0.340 |
Why?
|
| Cytoskeleton | 5 | 2024 | 195 | 0.340 |
Why?
|
| Adherens Junctions | 4 | 2020 | 34 | 0.310 |
Why?
|
| Radiation-Protective Agents | 1 | 2008 | 98 | 0.310 |
Why?
|
| Phosphatidylcholines | 6 | 2011 | 48 | 0.300 |
Why?
|
| Cytokines | 4 | 2019 | 802 | 0.270 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2024 | 89 | 0.270 |
Why?
|
| Cell Line | 7 | 2021 | 2495 | 0.260 |
Why?
|
| Placental Hormones | 1 | 2005 | 3 | 0.250 |
Why?
|
| Fibroblasts | 3 | 2024 | 755 | 0.240 |
Why?
|
| Histone Deacetylases | 3 | 2021 | 70 | 0.240 |
Why?
|
| Thrombin | 4 | 2020 | 61 | 0.240 |
Why?
|
| Phenazines | 1 | 2024 | 7 | 0.240 |
Why?
|
| Gentian Violet | 1 | 2024 | 10 | 0.230 |
Why?
|
| rac GTP-Binding Proteins | 3 | 2009 | 25 | 0.230 |
Why?
|
| rho-Associated Kinases | 2 | 2024 | 160 | 0.230 |
Why?
|
| NAD | 1 | 2024 | 71 | 0.230 |
Why?
|
| Sirtuin 1 | 1 | 2024 | 32 | 0.230 |
Why?
|
| Methanol | 2 | 2020 | 12 | 0.230 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2024 | 85 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2016 | 200 | 0.230 |
Why?
|
| Alveolar Epithelial Cells | 2 | 2020 | 18 | 0.230 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 91 | 0.230 |
Why?
|
| Benzenesulfonates | 1 | 2024 | 66 | 0.220 |
Why?
|
| Mycoses | 1 | 2024 | 46 | 0.220 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2024 | 64 | 0.220 |
Why?
|
| Pyrrolidines | 2 | 2020 | 59 | 0.220 |
Why?
|
| Animals, Newborn | 2 | 2021 | 524 | 0.210 |
Why?
|
| Antioxidants | 3 | 2011 | 226 | 0.210 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 299 | 0.210 |
Why?
|
| Gene Knockdown Techniques | 5 | 2015 | 247 | 0.210 |
Why?
|
| Epithelial Cells | 3 | 2021 | 688 | 0.210 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 315 | 0.210 |
Why?
|
| Vascular Diseases | 1 | 2023 | 118 | 0.210 |
Why?
|
| Genetic Therapy | 1 | 2005 | 370 | 0.210 |
Why?
|
| Mice, Knockout | 7 | 2020 | 1990 | 0.200 |
Why?
|
| Gene Deletion | 2 | 2020 | 342 | 0.200 |
Why?
|
| Pulmonary Artery | 5 | 2023 | 319 | 0.200 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 18 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2020 | 313 | 0.190 |
Why?
|
| Histones | 2 | 2021 | 329 | 0.190 |
Why?
|
| Tyrosine | 1 | 2021 | 133 | 0.190 |
Why?
|
| Microfilament Proteins | 2 | 2013 | 212 | 0.190 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 76 | 0.190 |
Why?
|
| Male | 21 | 2024 | 42251 | 0.190 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 1975 | 0.190 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2020 | 3 | 0.180 |
Why?
|
| Melanoma | 1 | 2005 | 467 | 0.180 |
Why?
|
| Airway Remodeling | 1 | 2020 | 9 | 0.180 |
Why?
|
| Plasmalogens | 1 | 2020 | 3 | 0.180 |
Why?
|
| Apoptosis | 5 | 2021 | 1716 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 340 | 0.180 |
Why?
|
| Iloprost | 2 | 2010 | 15 | 0.180 |
Why?
|
| Hypertension, Pulmonary | 1 | 2023 | 352 | 0.170 |
Why?
|
| Regeneration | 1 | 2020 | 150 | 0.170 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 257 | 0.160 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 2362 | 0.160 |
Why?
|
| Simvastatin | 1 | 2018 | 105 | 0.150 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2009 | 108 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2005 | 889 | 0.150 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 38 | 0.150 |
Why?
|
| Chondrocytes | 1 | 2017 | 64 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 82 | 0.150 |
Why?
|
| Oxidation-Reduction | 5 | 2010 | 387 | 0.150 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 308 | 0.140 |
Why?
|
| Cortactin | 1 | 2016 | 11 | 0.140 |
Why?
|
| Membrane Proteins | 4 | 2023 | 1215 | 0.140 |
Why?
|
| Oxidative Stress | 3 | 2023 | 458 | 0.140 |
Why?
|
| Cell Cycle | 1 | 2018 | 509 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2023 | 1650 | 0.130 |
Why?
|
| Respiration, Artificial | 2 | 2009 | 352 | 0.130 |
Why?
|
| RNA, Small Interfering | 7 | 2013 | 557 | 0.130 |
Why?
|
| Catenins | 2 | 2012 | 11 | 0.130 |
Why?
|
| Tyrphostins | 1 | 2015 | 8 | 0.130 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2015 | 34 | 0.130 |
Why?
|
| Lung Diseases | 1 | 2016 | 269 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 285 | 0.120 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2013 | 14 | 0.120 |
Why?
|
| Phosphoproteins | 2 | 2012 | 261 | 0.110 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2013 | 25 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1429 | 0.110 |
Why?
|
| rap1 GTP-Binding Proteins | 2 | 2012 | 13 | 0.110 |
Why?
|
| Tight Junctions | 2 | 2012 | 150 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2013 | 794 | 0.110 |
Why?
|
| p21-Activated Kinases | 2 | 2010 | 16 | 0.110 |
Why?
|
| NADPH Oxidase 2 | 1 | 2013 | 22 | 0.110 |
Why?
|
| NADPH Oxidase 4 | 1 | 2013 | 15 | 0.110 |
Why?
|
| Chemotaxis | 1 | 2013 | 73 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 267 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2020 | 1652 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 217 | 0.100 |
Why?
|
| Telomere-Binding Proteins | 1 | 2011 | 14 | 0.100 |
Why?
|
| Cyclic AMP | 2 | 2009 | 274 | 0.100 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 2 | 2010 | 16 | 0.100 |
Why?
|
| Interleukin-6 | 2 | 2010 | 261 | 0.090 |
Why?
|
| Immunoglobulins | 1 | 2011 | 144 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 167 | 0.090 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2010 | 39 | 0.090 |
Why?
|
| Sulfones | 2 | 2020 | 45 | 0.090 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2010 | 55 | 0.090 |
Why?
|
| Histone Deacetylase 2 | 2 | 2021 | 8 | 0.080 |
Why?
|
| Histone Deacetylase 1 | 2 | 2021 | 15 | 0.080 |
Why?
|
| Caveolin 1 | 1 | 2009 | 21 | 0.080 |
Why?
|
| Acetylation | 2 | 2021 | 132 | 0.080 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 54 | 0.080 |
Why?
|
| Receptors, LDL | 1 | 2009 | 54 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2009 | 323 | 0.080 |
Why?
|
| Female | 7 | 2021 | 46011 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2010 | 423 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2005 | 392 | 0.070 |
Why?
|
| Dinoprostone | 1 | 2007 | 70 | 0.070 |
Why?
|
| Epoprostenol | 1 | 2007 | 46 | 0.070 |
Why?
|
| Fibronectins | 2 | 2020 | 101 | 0.070 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2013 | 48 | 0.070 |
Why?
|
| Asthma | 1 | 2013 | 976 | 0.060 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2005 | 24 | 0.060 |
Why?
|
| Retroviridae | 1 | 2005 | 79 | 0.060 |
Why?
|
| Transgenes | 1 | 2005 | 185 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 153 | 0.060 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 3 | 2009 | 7 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 543 | 0.060 |
Why?
|
| ADAM10 Protein | 1 | 2023 | 7 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 646 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 192 | 0.060 |
Why?
|
| Electric Impedance | 3 | 2009 | 110 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 370 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2019 | 901 | 0.060 |
Why?
|
| Vascular Remodeling | 1 | 2023 | 22 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2024 | 168 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2005 | 446 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2023 | 93 | 0.060 |
Why?
|
| Ribonucleases | 1 | 2003 | 93 | 0.060 |
Why?
|
| Protein Transport | 2 | 2016 | 421 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 887 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 1574 | 0.050 |
Why?
|
| Zonula Occludens-1 Protein | 2 | 2012 | 70 | 0.050 |
Why?
|
| Acyltransferases | 1 | 2021 | 41 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 373 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2013 | 321 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2021 | 142 | 0.050 |
Why?
|
| Cell Count | 1 | 2020 | 200 | 0.040 |
Why?
|
| RNA Interference | 2 | 2013 | 376 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2020 | 78 | 0.040 |
Why?
|
| Random Allocation | 2 | 2010 | 328 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2020 | 150 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 2014 | 0.040 |
Why?
|
| Virulence | 1 | 2019 | 280 | 0.040 |
Why?
|
| Oligopeptides | 2 | 2010 | 188 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 519 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 187 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 315 | 0.040 |
Why?
|
| Smoking | 1 | 2021 | 620 | 0.040 |
Why?
|
| Actins | 2 | 2013 | 458 | 0.040 |
Why?
|
| beta Catenin | 2 | 2011 | 266 | 0.040 |
Why?
|
| DNA Damage | 1 | 2019 | 371 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2016 | 51 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 125 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 481 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 69 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1796 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1310 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 316 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 443 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 698 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 56 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 2439 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 197 | 0.030 |
Why?
|
| Allergens | 1 | 2013 | 183 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2013 | 268 | 0.030 |
Why?
|
| Collagen | 1 | 2013 | 293 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 428 | 0.020 |
Why?
|
| Occludin | 1 | 2011 | 66 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2010 | 26 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 426 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2010 | 101 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 125 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 273 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 5320 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 104 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2009 | 13 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 289 | 0.020 |
Why?
|
| Microtubules | 1 | 2010 | 123 | 0.020 |
Why?
|
| Rats | 2 | 2008 | 4040 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 178 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 253 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2008 | 38 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2010 | 479 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2007 | 10 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2007 | 19 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2010 | 465 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1521 | 0.020 |
Why?
|
| Phosphatidic Acids | 1 | 2006 | 4 | 0.020 |
Why?
|
| Permeability | 1 | 2007 | 137 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2006 | 20 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 699 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 412 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2006 | 228 | 0.020 |
Why?
|
| CD146 Antigen | 1 | 2005 | 4 | 0.020 |
Why?
|
| Immunomagnetic Separation | 1 | 2005 | 8 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2005 | 15 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2005 | 46 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2005 | 37 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 510 | 0.010 |
Why?
|
| Carbon Tetrachloride | 1 | 2003 | 6 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 2003 | 26 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 2003 | 24 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 2003 | 44 | 0.010 |
Why?
|
| Catalase | 1 | 2003 | 49 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 2003 | 71 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 74 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 112 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 159 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 357 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2003 | 177 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 911 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 982 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 645 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1940 | 0.010 |
Why?
|
| Liver | 1 | 2003 | 1205 | 0.010 |
Why?
|
| Oxygen | 1 | 2003 | 742 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 705 | 0.010 |
Why?
|
| Obesity | 1 | 2005 | 966 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 2863 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 2552 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 19077 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 25863 | 0.010 |
Why?
|